Journal of Innovation in Cardiac Rhythm Management
banner AtriCure HRS2024

 

Activity Description
This CME-accredited lunch symposium features leading experts who will examine the latest clinical trial data and real-world experiences of transformational treatment strategies, and evaluate their potential impact on daily practice.

The first session reviews the safety and efficacy of LAA exclusion for the prevention of ischemic stroke or systemic arterial embolism in cardiac surgery patients without Afib. The second session explores the role of sinus node-sparing hybrid ablation for the treatment of drug-refractory patients with Inappropriate Sinus Tachycardia (IST). Session three assesses post-approval study outcomes of Hybrid Convergent ablation for the treatment of symptomatic longstanding persistent Afib patients who have shown refractoriness or intolerance to AADs. The final session evaluates the safety and efficacy of dual epicardial and endocardial ablation in patients presented with persistent or longstanding persistent Afib.

The presentations are complemented with panel discussions and Q&A sessions that provide an interactive venue for direct faculty engagement.

Date
Friday, May 17, 2024

Times
11:30 AM – 12:15 PM EST: Check-In and Lunch Buffet
12:15 – 2:00 PM EST: Educational Program

Location
Boston Convention and Exhibition Center Room 205ABC

 

Agenda

Agenda

11:30 AM - 12:15 PM

 

Check-In and Lunch Buffet

12:15 - 12:20 AM

 

Welcome and Introductions
Devi Nair, MD

12:20 - 12:35 PM

 

LeAAPS Clinical Trial
Patrick McCarthy, MD

12:35 - 12:45 PM

 

Panel Discussion with Q&A
Moderator: Devi Nair, MD
Panelists: Patrick McCarthy, MD, Dhanunjaya Lakkireddy, MD, David DeLurgio, MD and Kenneth Ellenbogen, MD

12:45 - 1:00 PM

 

HEAL-IST Study
Dhanunjaya Lakkireddy, MD

1:00 - 1:10 PM

 

Panel Discussion with Q&A
Moderator: Devi Nair, MD
Panelists: Dhanunjaya Lakkireddy, MD, Patrick McCarthy, MD, David DeLurgio, MD and Kenneth Ellenbogen, MD

1:10 - 1:25 PM

 

CONVERGE Post-Approval Study
David DeLurgio, MD

1:25 - 1:35 PM

 

Panel Discussion with Q&A
Moderator: Devi Nair, MD
Panelists: David DeLurgio, MD, Dhanunjaya Lakkireddy, MD, Patrick McCarthy, MD and Kenneth Ellenbogen, MD

1:35 - 1:50 PM

 

DEEP Pivotal Study 
Kenneth Ellenbogen, MD

1:50 - 2:00 PM

 

Panel Discussion with Q&A
Moderator: Devi Nair, MD
Panelists: Kenneth Ellenbogen, MD, David DeLurgio, MD, Dhanunjaya Lakkireddy, MD, and Patrick McCarthy, MD 


Commercial Support
The activity is supported through an educational grant from AtriCure, Inc.

Joint Providership:
MediaSphere Medical, LLC and Ciné-Med

 

Faculty

Program Chair and Moderator

Devi Nair MD

Devi Nair, MD, FACC, FHRS
Director of the Cardiac Electrophysiology Division
St. Bernard’s Heart & Vascular Center
Jonesboro, AR

Presenters and Panelists

David DeLurgio MD

David DeLurgio, MD, FACC, FHRS
Professor of Medicine; Emory University School of Medicine
Director of Electrophysiology; Emory St. Joseph’s Hospital
Atlanta, GA

Kenneth Ellenbogen MD

Kenneth Ellenbogen, MD, FHRS
Martha M. and Harold W. Kimmerling Professor of Cardiology
Director Electrophysiology and Pacing
VCU School of Medicine
Richmond, VA

Dhanunjaya Lakkireddy MD

Dhanunjaya Lakkireddy, MD, FACC, FHRS  
Executive Medical Director
Kansas City Heart Rhythm Institute at HCA Midwest Health
Overland Park, KS

Patrick McCarthy MD

Patrick McCarthy, MD, FACC
Executive Director, Bluhm Cardiovascular Institute
Vice President, Northwestern Medical Group
Heller-Sacks Professor of Surgery
Chicago, IL

   

CME Accreditation

Activity Goal
This activity is designed to address the following core and team competencies:
Patient care, medical knowledge, practice-based learning and improvement, interprofessional collaboration, and roles and responsibilities.

Target Audience
The symposium is intended to meet the educational needs of Electrophysiologists, Cardiologists, Cardiac and Cardiothoracic Surgeons, Fellows-in-Training, and Allied Healthcare Professionals with a clinical focus of cardiac arrhythmia and left atrial appendage management.  

Learning Objectives
Upon completion of this educational activity, participants will be able to:

  • Assess the safety and efficacy of LAA exclusion for the prevention of ischemic stroke or systemic arterial embolism in cardiac surgery patients without Afib, who are at elevated risk for these events.
  • Examine the role of sinus node sparing hybrid ablation for the treatment of drug-refractory patients with Inappropriate Sinus Tachycardia (IST).
  • Discuss the safety and efficacy of Hybrid Convergent ablation for the treatment of symptomatic longstanding persistent AF who are refractory or intolerant to AADs.
  • Assess the safety and efficacy of dual epicardial and endocardial ablation in a cohort of patients presented with persistent or longstanding persistent AF.

Accreditation Statement
Jointly Accredited Provider TMTo support the improvement of patient care, this activity has been planned and implemented by MediaSphere Medical and Ciné-Med. Ciné-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health-care team.

Ciné-Med designates this educational activity for a maximum of 2 AMA PRA CATEGORY 1 Credit(s)™ for Physicians. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Ciné-Med designates this activity for 2 Contact Hours for Nurses.


Disclosure Policy
MediaSphere Medical and Ciné-Med adheres to accreditation requirements concerning industry support of continuing medical education. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations. Speakers will disclose any relationships at the beginning of their presentations.

All MediaSphere Medical and Ciné-Med employees in control of content have indicated that they have no relevant financial relationships to disclose.

It is the policy of MediaSphere Medical and Ciné-Med to ensure balance, independent objectivity, and scientific rigor in all its supported educational programs. All faculty members participating in educational activities are required to disclose to the program audience any real of apparent conflicts of interest held within the past 12 months.

MediaSphere Medical and Ciné-Med implement a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.

Non-Endorsement Statement
MediaSphere Medical and Ciné-Med verify that sound education principles have been demonstrated in the development of this educational offering as evidenced by the review of its objectives, teaching plan, faculty, and activity evaluation process. MediaSphere Medical and Ciné-Med does not endorse or support the actual opinions or material content as presented by the speaker(s) and/or sponsoring organization.


Commercial Support
The activity is supported through an educational grant from AtriCure, Inc.

Joint Providership:
MediaSphere Medical, LLC and Ciné-Med

 

“This program is not part of the Heart Rhythm 2024 Official Scientific Sessions as planned by the
Heart Rhythm Society Scientific Sessions Program Committee.
The event is neither sponsored nor endorsed by the Heart Rhythm Society”